SCHEMBL20775013

SCHEMBL20775013

CCOC(=O)c1ncc(C)c2sc(Cl)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
TP53 P04637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 2/20 0.41
XBP1 P17861 1/20 0.41
HTT P42858 1/20 0.41
TLR9 Q9NR96 1/20 0.41
KMT2A Q03164 3/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GABRA1 P14867 4/20 0.39
GABRG2 P18507 4/20 0.39
GABRB3 P28472 4/20 0.39
GABRA5 P31644 4/20 0.39
GABRA3 P34903 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20772240 0.76 GABRG2 (0.44) ALDH1A1NPSR1MAPTNPC1TP53
SCHEMBL20772000 0.72 ALDH1A1 (0.42) ALDH1A1NPSR1MAPTNPC1TP53
SCHEMBL7669745 0.72 MAPT (0.48) ALDH1A1NPSR1MAPTNPC1TP53
SCHEMBL20785461 0.71 GLP1R (0.44) ALDH1A1NPSR1MAPTNPC1TP53
SCHEMBL11578876 0.71 MAPT (0.49) ALDH1A1MAPTHSD17B10MAPK1KMT2A
SCHEMBL20772001 0.71 SELE (0.32)
SCHEMBL10997351 0.70 KMT2A (0.46) ALDH1A1MAPTNPC1TP53HSD17B10
SCHEMBL9836815 0.69 KMT2A (0.43) ALDH1A1NPSR1MAPTHSD17B10MAPK1
SCHEMBL6492223 0.69 MAPT (0.51) ALDH1A1NPSR1MAPTNPC1TP53
SCHEMBL17173720 0.69 MAPT (0.51) ALDH1A1NPSR1MAPTNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3675856-A1 COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR Corvus Pharmaceuticals, Inc. (US) 2020-07-08 EP disclosed
WO-2019046784-A1 COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADENOSINE A2A RECEPTOR CORVUS PHARMACEUTICALS, INC. (US) 2019-03-07 WO disclosed